Literature DB >> 8039923

An in vitro model for immune control of chlamydial growth in polarized epithelial cells.

J U Igietseme1, P B Wyrick, D Goyeau, R G Rank.   

Abstract

A polarized epithelial culture system and chlamydia-specific T-cell lines and clones were employed to investigate the ability and mechanisms by which T cells control the growth of chlamydiae in epithelial cells. Monolayers of polarized mouse epithelial cells were infected with the Chlamydia trachomatis agent of mouse pneumonitis (MoPn) and then exposed to antigen-stimulated MoPn-specific T-cell lines and clones. The results revealed that in vivo-protective MoPn-specific T-cell lines and clone 2.14-0 were capable of inhibiting the growth of MoPn in polarized epithelial cells. In contrast, the nonprotective MoPn-specific T-cell clone 2.14-3, naive splenic T cells, and a control T-cell clone could not inhibit the growth of MoPn in epithelial cells. Transmission electron microscopic analysis of infected epithelial cells which were exposed to clone 2.14-0 confirmed the absence of an established infection, as deduced from the virtual absence of inclusions in the cells. Antigen-specific activation of clone 2.14-0 was required for the MoPn-inhibitory function, since the absence of antigenic stimulation or stimulation with a heterologous chlamydial agent did not result in MoPn growth inhibition. Activation of clone 2.14-0 resulted in acquisition of the capacity to inhibit growth of both homologous (MoPn) and heterologous chlamydial agents. Close interaction between epithelial cells and clone 2.14-0 was required for the MoPn-inhibitory action, because separation of the cell types by a filter with a pore size of 0.45, 3.0, or even 8.0 microns abrogated MoPn inhibition. Protective T cells may act at close range in the epithelium to control chlamydial growth, possibly involving short-range-acting cytokines. The ability of antigen-stimulated T-cell lines and clones to inhibit chlamydial growth in polarized epithelial cultures could be a useful method for identifying protective T-cell clones and antigenic peptide fragments containing protective epitopes.

Entities:  

Mesh:

Year:  1994        PMID: 8039923      PMCID: PMC302987          DOI: 10.1128/iai.62.8.3528-3535.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Immunity to chlamydial infections of the eye. IV. Immunity in owl monkeys to reinfection with trachoma.

Authors:  C E Fraser; D E McComb; E S Murray; A B MacDonald
Journal:  Arch Ophthalmol       Date:  1975-07

2.  The effect of antigen deprivation on thymus-dependent and thymus-independent lymphocytes in the small intestine of the mouse.

Authors:  A Ferguson; D M Parrott
Journal:  Clin Exp Immunol       Date:  1972-12       Impact factor: 4.330

3.  Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues.

Authors:  M R McDermott; J Bienenstock
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

4.  Establishment and characterization of two distinct mouse testicular epithelial cell lines.

Authors:  J P Mather
Journal:  Biol Reprod       Date:  1980-08       Impact factor: 4.285

5.  Immunohistological characterisation of intraepithelial lymphocytes of the human gastrointestinal tract.

Authors:  W S Selby; G Janossy; D P Jewell
Journal:  Gut       Date:  1981-03       Impact factor: 23.059

6.  An animal model for cicatrizing trachoma.

Authors:  H R Taylor; R A Prendergast; C R Dawson; J Schachter; A M Silverstein
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-09       Impact factor: 4.799

7.  Humoral immune response in acquired immunity to chlamydial genital infection of female guinea pigs.

Authors:  R G Rank; A L Barron
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

8.  Immunity to vaginal reinfection in female guinea pigs infected sexually with Chlamydia of guinea pig inclusion conjunctivitis.

Authors:  H C Lamont; D Z Semine; C Leveille; R L Nichols
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

9.  Immunity to reinfection of the genital tract of marmosets with Chlamydia trachomatis.

Authors:  A P Johnson; M F Osborn; B J Thomas; C M Hetherington; D Taylor-Robinson
Journal:  Br J Exp Pathol       Date:  1981-12

10.  Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone.

Authors:  J U Igietseme; K H Ramsey; D M Magee; D M Williams; T J Kincy; R G Rank
Journal:  Reg Immunol       Date:  1993 Nov-Dec
View more
  14 in total

1.  T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Authors:  X Yang; R Brunham
Journal:  Can J Infect Dis       Date:  1998-03

2.  The intercellular adhesion molecule type-1 is required for rapid activation of T helper type 1 lymphocytes that control early acute phase of genital chlamydial infection in mice.

Authors:  J U Igietseme; G A Ananaba; J Bolier; S Bowers; T Moore; T Belay; D Lyn; C M Black
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

3.  Chlamydia-specific CD4 T cell clones control Chlamydia muridarum replication in epithelial cells by nitric oxide-dependent and -independent mechanisms.

Authors:  Krupakar Jayarapu; Micah Kerr; Susan Ofner; Raymond M Johnson
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

4.  PmpG303-311, a protective vaccine epitope that elicits persistent cellular immune responses in Chlamydia muridarum-immune mice.

Authors:  Raymond M Johnson; Hong Yu; Micah S Kerr; James E Slaven; Karuna P Karunakaran; Robert C Brunham
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

5.  Chlamydia muridarum-specific CD4 T-cell clones recognize infected reproductive tract epithelial cells in an interferon-dependent fashion.

Authors:  Krupakar Jayarapu; Micah S Kerr; Adrian Katschke; Raymond M Johnson
Journal:  Infect Immun       Date:  2009-08-10       Impact factor: 3.441

6.  Plac8-dependent and inducible NO synthase-dependent mechanisms clear Chlamydia muridarum infections from the genital tract.

Authors:  Raymond M Johnson; Micah S Kerr; James E Slaven
Journal:  J Immunol       Date:  2012-01-11       Impact factor: 5.422

7.  Discordance in the Epithelial Cell-Dendritic Cell Major Histocompatibility Complex Class II Immunoproteome: Implications for Chlamydia Vaccine Development.

Authors:  Karuna P Karunakaran; Hong Yu; Xiaozhou Jiang; Queenie W T Chan; Leonard J Foster; Raymond M Johnson; Robert C Brunham
Journal:  J Infect Dis       Date:  2020-02-18       Impact factor: 5.226

8.  Molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide in vivo.

Authors:  J U Igietseme
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

9.  CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract.

Authors:  H Su; H D Caldwell
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Chlamydia trachomatis infection results in a modest pro-inflammatory cytokine response and a decrease in T cell chemokine secretion in human polarized endocervical epithelial cells.

Authors:  Lyndsey R Buckner; Maria E Lewis; Sheila J Greene; Timothy P Foster; Alison J Quayle
Journal:  Cytokine       Date:  2013-05-11       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.